[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 21, 1954


Author Affiliations

Kansas City, Mo.

From the Children's Convalescent Center and the departments of pediatrics and medical microbiology of the University of Kansas Medical Center, Kansas City, Kan.

JAMA. 1954;155(17):1466-1470. doi:10.1001/jama.1954.03690350008003

The problem of prevention of recurrent attacks of rheumatic fever has always presented a great challenge to the responsible physician. Prior to the advent of chemotherapeutic and antibiotic agents, the avoidance of streptococcic disease and the general symptomatic care of the patient proved fruitless in attempting to prevent progressive cardiac damage in the patient who had had rheumatic fever. Tonsillectomy has not prevented recurrences of the disease, and now it is usually felt that patients with histories of rheumatic fever have the same indications for removal of the tonsils as do those who have not been afflicted with the disease. The strongest evidence for a direct relationship between rheumatic activity and antecedent streptococcic infection has been presented by prophylactic programs.

The sulfonamides were used in the first direct approach to the prevention of recurrences by attempting to keep the throat free of beta hemolytic streptococci of Lancefield group A. Because

First Page Preview View Large
First page PDF preview
First page PDF preview